Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lipopolysaccharides | 2 | 2023 | 37 | 0.710 |
Why?
|
| Glycolysis | 1 | 2019 | 2 | 0.680 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 2 | 0.680 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2019 | 6 | 0.680 |
Why?
|
| Chemokines | 1 | 2019 | 9 | 0.670 |
Why?
|
| Neoplasms | 1 | 2019 | 141 | 0.580 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 61 | 0.400 |
Why?
|
| Nanoparticles | 2 | 2023 | 104 | 0.390 |
Why?
|
| Wound Healing | 2 | 2024 | 24 | 0.280 |
Why?
|
| Tissue Scaffolds | 2 | 2024 | 45 | 0.280 |
Why?
|
| Nanospheres | 2 | 2023 | 13 | 0.260 |
Why?
|
| Rats, Wistar | 1 | 2024 | 13 | 0.230 |
Why?
|
| Melanoma | 1 | 2024 | 8 | 0.230 |
Why?
|
| Skin Neoplasms | 1 | 2024 | 12 | 0.230 |
Why?
|
| Nanofibers | 1 | 2024 | 13 | 0.230 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 274 | 0.220 |
Why?
|
| Polysaccharides | 1 | 2024 | 45 | 0.220 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 8 | 0.220 |
Why?
|
| Apoptosis | 2 | 2022 | 39 | 0.220 |
Why?
|
| Oils, Volatile | 1 | 2023 | 10 | 0.210 |
Why?
|
| Animals | 5 | 2024 | 1063 | 0.210 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 31 | 0.210 |
Why?
|
| Tankyrases | 1 | 2022 | 4 | 0.210 |
Why?
|
| Alginates | 1 | 2023 | 32 | 0.210 |
Why?
|
| Metal Nanoparticles | 1 | 2023 | 25 | 0.210 |
Why?
|
| Biocompatible Materials | 1 | 2023 | 60 | 0.210 |
Why?
|
| Mice | 4 | 2024 | 134 | 0.210 |
Why?
|
| Tissue Engineering | 1 | 2023 | 52 | 0.210 |
Why?
|
| Praziquantel | 1 | 2022 | 5 | 0.210 |
Why?
|
| Ferrous Compounds | 1 | 2022 | 4 | 0.200 |
Why?
|
| Diphosphonates | 1 | 2022 | 4 | 0.200 |
Why?
|
| Macromolecular Substances | 1 | 2021 | 5 | 0.190 |
Why?
|
| Nanomedicine | 1 | 2021 | 23 | 0.180 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2019 | 7 | 0.170 |
Why?
|
| THP-1 Cells | 1 | 2019 | 6 | 0.170 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 15 | 0.170 |
Why?
|
| Humans | 8 | 2024 | 14077 | 0.170 |
Why?
|
| Signal Transduction | 1 | 2019 | 33 | 0.170 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 250 | 0.160 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 70 | 0.160 |
Why?
|
| Tuberculosis | 1 | 2023 | 530 | 0.140 |
Why?
|
| Bandages | 2 | 2023 | 19 | 0.110 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2022 | 10 | 0.100 |
Why?
|
| Molecular Structure | 2 | 2022 | 31 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2022 | 43 | 0.100 |
Why?
|
| Particle Size | 2 | 2022 | 72 | 0.100 |
Why?
|
| Drug Carriers | 2 | 2022 | 93 | 0.090 |
Why?
|
| Polydioxanone | 1 | 2024 | 2 | 0.060 |
Why?
|
| Carrageenan | 1 | 2024 | 3 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 16 | 0.060 |
Why?
|
| Rats | 1 | 2024 | 130 | 0.060 |
Why?
|
| Paclitaxel | 1 | 2023 | 5 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 14 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2023 | 14 | 0.050 |
Why?
|
| Poloxamer | 1 | 2023 | 7 | 0.050 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2023 | 8 | 0.050 |
Why?
|
| Gram-Positive Bacteria | 1 | 2023 | 9 | 0.050 |
Why?
|
| Osteogenesis | 1 | 2023 | 3 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2023 | 3 | 0.050 |
Why?
|
| Bone Regeneration | 1 | 2023 | 5 | 0.050 |
Why?
|
| Gram-Negative Bacteria | 1 | 2023 | 15 | 0.050 |
Why?
|
| Gels | 1 | 2023 | 17 | 0.050 |
Why?
|
| Rabbits | 1 | 2023 | 35 | 0.050 |
Why?
|
| Peptides | 1 | 2023 | 40 | 0.050 |
Why?
|
| Silver | 1 | 2023 | 15 | 0.050 |
Why?
|
| Printing, Three-Dimensional | 1 | 2023 | 21 | 0.050 |
Why?
|
| Mannose | 1 | 2023 | 5 | 0.050 |
Why?
|
| Macrophages | 1 | 2023 | 15 | 0.050 |
Why?
|
| beta Catenin | 1 | 2022 | 5 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 5 | 0.050 |
Why?
|
| Skin | 1 | 2023 | 38 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 23 | 0.050 |
Why?
|
| Fluorouracil | 1 | 2022 | 19 | 0.050 |
Why?
|
| Liposomes | 1 | 2022 | 33 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 45 | 0.050 |
Why?
|
| Lipids | 1 | 2022 | 81 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2022 | 27 | 0.050 |
Why?
|
| Isoniazid | 1 | 2023 | 110 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2022 | 79 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2022 | 124 | 0.050 |
Why?
|
| Rifampin | 1 | 2023 | 189 | 0.050 |
Why?
|
| Prolamins | 1 | 2021 | 3 | 0.050 |
Why?
|
| Iridoids | 1 | 2021 | 7 | 0.050 |
Why?
|
| Azo Compounds | 1 | 2021 | 6 | 0.050 |
Why?
|
| Rheology | 1 | 2021 | 13 | 0.050 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 9 | 0.050 |
Why?
|
| X-Ray Diffraction | 1 | 2021 | 14 | 0.050 |
Why?
|
| Phototherapy | 1 | 2021 | 6 | 0.050 |
Why?
|
| Light | 1 | 2021 | 11 | 0.050 |
Why?
|
| Injections | 1 | 2021 | 30 | 0.050 |
Why?
|
| Temperature | 1 | 2021 | 56 | 0.050 |
Why?
|
| Hydrogels | 1 | 2021 | 42 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 220 | 0.040 |
Why?
|